ArticleJournal of Ayurveda and integrative medicine
Efficacy of Mamsyadi Ghana capsule in Insomnia Disorder - A randomized controlled trial.
Article in Journal of Ayurveda and integrative medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInsomnia disorder is a common sleep disorder. Mamsyadi Ghana Capsule (Ayurveda medication) is assessed for its role in the management of Insomnia disorder.
objectiveThe study was planned to evaluate the efficacy of Mamsyadi Ghana Capsule in the management of Insomnia disorder
methods50 patients attending the OPD of the institute, meeting the diagnostic criteria of Insomnia Disorder (DSM 5) of age group 20-80 years of both sex participated in the study. They were randomly divided and Tagara Churna group (TC) received Tagara Churna (Valeriana wallichi DC) 4 gram and Mamsyadi Ghana group (MG) received Mamsyadi Ghana Capsule 500 mg respectively thrice a day for 30 days. Evaluations were done through Insomnia severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness scale (ESS), Sleep diary recordings of past 15 days and depression Anxiety and Stress Scale (DASS). Clinical assessments were on 15th and 30th day. Blood parameters like haemoglobin, liver function tests, serum creatinine were evaluated at baseline and post study.
resultsStudy showed that Mamsyadi Ghana Capsule produced significant improvement compared to Tagara Churna in ISI and ESS (p = 0.01) and effect size was large. Both interventions were comparable in PSQI, DASS, sleep diary variables. Both the interventions produced significant improvement in ISI, ESS, PSQI, DASS (p < 0.001) and sleep diary variables on within group comparison. Serum Creatinine and Liver function tests showed that both the interventions had good safety profile.
conclusionStudy showed that Mamsyadi Ghana Capsule is better than the Tagara Churna in Insomnia Disorder and both showed anxiolytic and antidepressant effect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.